atypical antipsychotic pharmacology
Post on 24-Feb-2016
152 Views
Preview:
DESCRIPTION
TRANSCRIPT
Atypical Antipsychotic pharmacology
Atypical Antipsychotic PharmacologyUsing Receptor Binding Profiles to Predict Adverse Effects
Stephanie Nichols, Pharm.D., BCPS, BCPPAssociate Professor of Pharmacy PracticeNicholsS@Husson.edu
ObjectivesRecognize atypical antipsychotics by brand and generic nameUnderstand how key pharmacological properties of antipsychotics translate into side effects Compare and contrast the pharmacology of the atypical antipsychotics Predict which antipsychotics may be more, or less, desirable in various patient scenariosChlorpromazineZiprasidoneAripiprazoleRisperidoneDroperidolAsenapineMesoridazineIloperidoneQuetiapineLurasidoneOlanzapineClozapineLoxapinePimozidePerphenazineTrifluoperazineProchlorperazineThiothixeneFluphenazineHaloperidolThioridazinePaliperidone1950201019801970196020001990Stephanie Nichols, PharmD BCPS BCPP 2014FDA Approval of AntipsychoticsWhat defines an Antipsychotic?Dopamine2 post synaptic antagonism
Reduce DA in the mesolimbic tractNucleus accumbens
Positive SymptomsEPS
Antagonism Partial Agonism
Dopamine PathwayFunctionDopamine Pathology in SchizophreniaAnti-Psychotic EfficacyAntipsychotic ToxicityNigrostriatalExtrapyramidal system & movementParkinsonism, dystonia, & dyskinesiaMesolimbicEmotions & motivationPlethoraPositive SymptomsMesocorticalCognition & executive functionPaucityNegative & Cognitive SymptomsAkathisiaTurbero-infundibularRegulates prolactin releaseHyper-prolactinemia
http://psychopharmacologyinstitute.com/antipsychotics-videos/dopamine-pathways-antipsychotics-pharmacology/Mesolimbic VTA to NA, HC, amygdalaMesocortical VTA to PFCNigrostriatal SN to BGTuberoinfundibular Hypothalamus to Pituitary Gland
What defines an Atypical Antipsychotic?Serotonin2a post-synaptic antagonism
5HT2a puts the brakes on DA in PFCDisinhibiting the inhibitor increased mesocortical DA
? Improved negative and cognitive symptomsReduced EPS at what cost?Typicals vs. AtypicalsRecognize atypical antipsychotics by brand and generic name
Atypical Antipsychotics in the USGeneric AvailabilityClozapine (Clozaril)Olanzapine (Zyprexa)Quetiapine (Seroquel)Risperidone (Risperdal)Ziprasidone (Geodon)Brand Name OnlyAripiprazole (Abilify)Paliperidone (Invega)Iloperidone (Fanapt)Asenapine (Saphris)Lurasidone (Latuda)Understand how key pharmacological properties of antipsychotics translate into side effects
Receptor Antagonism & Clinical EffectThe GoodThe BadD1 (agonism)?ameliorate cognitive deficits via DA modulation in PFC?Effects on moodD2 (antagonism)DA antagonism in the Mesolimbic Tract - positive sxEPS (parkinsonism, dystonia, dyskinesia, akathisia),hyperprolactinemia (ammenorrhea, galactorrhea, gynecomastia)The GoodThe Bad5HT1a (partial / full agonism)Antidepressant and/or anxiolytic ?Inhibit () glutamate release - positive sx
5HT2a (antagonism / inverse agonism) DA disinhibition (DA) in the:Nigrostriatal tract - EPSMesocortical tract - ? negative and cognitive sxSedation 5HT2c (antagonism / inverse agonism)Weight gain and metabolic dysfunction (hyperlipidemia, hypertriglyceridemia, hyperglycemia)5HT7 (antagonism)Circadian rhythm?pro-cognitive effects?Effects on anxiety or depression
Sedation? The GoodThe BadAlpha2a (antagonism)?Pro-cognitive effectsAlpha2c (antagonism)?Pro-cognitive effectsThe GoodThe BadAlpha7-nicotinic (antagonism)?mood and cognitionThe GoodThe BadAlpha1 (antagonism)Dizziness, orthostasis, hypotension, tachycardia, sedationH1 (antagonism)Sedation, weight gain and metabolic dysfunction?cognitionM1 (antagonism)Anticholinergic sx/sx, memory and cognitive deficitsM3 (antagonism)
?diabetes mellitusCompare and contrast the pharmacology of the atypical antipsychotics
Addressing Negative Symptoms in Schizophrenia. CPNP University 2013
NIMH Psychoactive Drug Screening Program (PDSP) KiDatabase:http://pdsp.med.unc.edu/pdsp.php
What do you think?Based upon Quetiapines binding profile, which of the following adverse effects is most likely to occur?ParkinsonismAntimuscarinic EffectsSedation
BDNFD25HT2a5HT1a5HT7a2a1H15HT2cM1Clozapine++++++++++++++++++Olanzapine+++++++0+++++++++++++++++++Quetiapine (Norquetiapine)+ (+)+++ (++++)0 (++)++ (0)+ (+)+++ (+++)++++ (++++)0 (+++)0 (+++)Risperidone (Paliperidone)+++ (++++)++++ (++++)+ (+)+++(++++)+ (+++)+++ (+++)++ (++)+++ (++)0 (0)Ziprasidone+++++++++++++++++++++0Aripiprazole++++(p.ag)+++++++++++++++++++++++0Paliperidone+++++++++++++++++++++++0Asenapine++++++++++++++++++++++++0Iloperidone+++++++++++++++++++++++++0Lurasidone++++++++++++++++++++0+00++++++++++D25HT2a5HT1a5HT7a2a1H15HT2cM1ClozapineOlanzapineQuetiapine (Norquetiapine)Risperidone (Paliperidone)ZiprasidoneAripiprazolePaliperidoneAsenapineIloperidoneLurasidone0++++++++++Metabolic ChangesDyslipidemia and hypertriglyceridemia pancreatitisHyperglycemia and insulin resistancediabetic ketoacidosis Increased body weightIncreased adiposity5HT2c and H1Quetiapine Metabolic EffectsEven low dose (0.05QTc Prolongationasenapineclozapineolanzapine
lurasidonequetiapinerisperidone
Predict which antipsychotics may be more, or less, desirable in various patient scenarios
Diabetes, Obesity or Metabolic SyndromeUsually Weight NeutralAripiprazole (except with 5HT antidepressants)LurasidoneZiprasidone
Most Weight GainClozapineOlanzapineQuetiapine
5HT2cH1Parkinsons Disease or History of Extra Pyramidal Symptoms (EPS)Less likely to cause EPSClozapineQuetiapine
More EPSParkinsonism and DystoniaRisperidonePaliperidoneAkathisiaAripiprazoleLurasidoneAsenapineZiprasidone
D2Orthostatic Hypotension, Dizziness, or Recurrent FallsHighest RiskClozapineRisperidoneIloperidoneQuetiapineLower RiskAripiprazoleLurasidoneZiprasidone1TitrateInsomniaMore SedatingQuetiapineClozapine
Less SedatingAripiprazoleZiprasidone
H15HT2a1History of Hyperprolactinemia or Concerns About its OccurrenceMore HyperprolactinemiaRisperidonePaliperidone
Less HyperprolactinemiaClozapineAripiprazoleIloperidoneAsenapineQuetiapineD2History of Ventricular ArrhythmiasMore likely to prolong QTcZiprasidoneIloperidone
Less likely to prolong QTcAripiprazole?LurasidoneK+ channel blockadeWill adjusting the dose fix the problem?Dose related effectsEPSSedationAmenorrheaAgitationActivationNon-dose related effectsWeight gainMetabolic changes
Aripiprazole somnolence at higher dosesZiprasidone activating at lower doses (5HT2c)Quetiapine less sedating at higher dosesSedationWeight gainParkisonismAkathisiaQTc prolongationHyper-prolactinemiaOrthostatic hypotensionAnticholinergic effectsAripiprazole++ (+++)+++++++++++Asenapine++++++++++++++++++++++Clozapine++++++++++++++++++++++++++Iloperidone++++++++++++++++++++++Lurasidone++++++++++++++++++++Olanzapine+++++++++++++++++++++++++Paliperidone+++++++++++++++++++++++++++Quetiapine+++++++++++++++++++++++Risperidone+++++++++++++++++++++++++++Ziprasidone++++++++++++++++++++++Take Home PointsD2 antagonism = positive symptomsEPS (ex. parkinsonism, dystonia) = high D2 antagonism Risperidone, paliperidone5HT2a antagonism = EPS may help with (or not exacerbate) negative and cognitive symptomsHistamine1, alpha1, and muscarinic antagonism = side effectsQuetiapine, clozapine, and olanzapine5HT2c + H1 antagonism = metabolic dysregulation & weight gainOlanzapine, clozapineEffects of binding 5HT1a, 5HT7, alpha2a, and alpha2c are still not fully understood but felt to contribute to efficacyThank you!!
NicholsS@Husson.edu
top related